Browsing Tag
oncology therapeutics
2 posts
MacroGenics exits GMP manufacturing operations as Bora expands U.S. biologics footprint
MacroGenics’ $122.5 million Bora sale boosts MGNX cash flexibility while shifting GMP manufacturing to a CDMO model.
General Proximity inks Daiichi Sankyo deal to push precision small molecules into oncology
General Proximity partners with Daiichi Sankyo to develop proximity-based cancer drugs using OmniTAC. Discover how this biotech is redefining drug discovery.